Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Eur Urol. 2017 Dec 10;74(1):107–114. doi: 10.1016/j.eururo.2017.11.024

Table 2 –

Univariable (UVA) and multivariable (MVA) of Decipher adjusting for detectable prostate-specific antigen (PSA) and clinical data for prediction of metastasis for the overall cohort

Variables Category UVA MVA
HR (95% CI) p value HR (95% CI) p value
Decipher risk (2 categories) Low/intermediate Ref
High 7.71 (2.88–23.3) <0.001 5.95 (2.02–19.4) 0.001
Pre-operative PSAa 1.55 (0.95–2.43) 0.08 1.24 (0.79–1.92) 0.4
Group 1 & 2 Ref
RP grade groups Group 3 3.04 (0.92–11.0) 0.07 1.57 (0.45–5.95) 0.5
Group 4 & 5 5.1 (1.55–18.4) 0.008 1.53 (0.42–6.06) 0.5
Positive surgical margins 3.76 (1.42–9.93) 0.009 1.22 (0.4–4.05) 0.7
Lymph node invasion 9.74 (2.85–27.9) <0.001 12.18 (2.46–70.7) 0.003
T2 Ref
Pathological stage T3a 7.93 (1.73–75.19) 0.006 4.74 (0.96–46.3) 0.056
T3b & T4 11.5 (2.59–108.4) <0.001 4.6 (0.95–44.9) 0.059
Detectable PSA 2.36 (0.89–6.72) 0.08 4.26 (1.16–21.8) 0.03

CI = confidence interval; HR = hazard ratio; Ref = reference; RP = radical prostatectomy.

a

Preoperative PSA values were log2 transformed.